Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 494

1.

Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.

Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP.

JAMA Psychiatry. 2014 Dec 1;71(12):1364-72. doi: 10.1001/jamapsychiatry.2014.1325.

PMID:
25271822
2.

Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation.

Salavati B, Rajji TK, Price R, Sun Y, Graff-Guerrero A, Daskalakis ZJ.

Schizophr Bull. 2015 Jan;41(1):44-56. doi: 10.1093/schbul/sbu132. Epub 2014 Sep 22.

PMID:
25249654
3.

Neurophysiological correlates of metabolic syndrome and cognitive impairment in schizophrenia: a structural equation modeling approach.

Boyer L, Testart J, Michel P, Richieri R, Faget-Agius C, Vanoye V, Auquier P, Lancon C, Guedj E.

Psychoneuroendocrinology. 2014 Dec;50:95-105. doi: 10.1016/j.psyneuen.2014.07.019. Epub 2014 Aug 10.

PMID:
25199983
4.

The effects of aging on changes in regional cerebral blood flow in schizophrenia.

Kawakami K, Wake R, Miyaoka T, Furuya M, Liaury K, Horiguchi J.

Neuropsychobiology. 2014;69(4):202-9. doi: 10.1159/000358840. Epub 2014 May 23.

PMID:
24863665
5.

Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications.

Uchida H, Suzuki T.

J Clin Psychopharmacol. 2014 Dec;34(6):728-35. doi: 10.1097/JCP.0000000000000065.

PMID:
24781442
6.

Cerebral blood flow changes after transcranial direct current stimulation for a patient with schizophrenia: a case report.

Shiozawa P, Santos MM, Piovesan FX, Pellegrinelli A, Enokibara da Silva M, Bocato MQ, Cordeiro Q, Fregni F, Brunoni AR.

J Neuropsychiatry Clin Neurosci. 2014 Apr 1;26(2):E03-5. doi: 10.1176/appi.neuropsych.13020039. No abstract available.

PMID:
24763768
7.

In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.

Esterlis I, Ranganathan M, Bois F, Pittman B, Picciotto MR, Shearer L, Anticevic A, Carlson J, Niciu MJ, Cosgrove KP, D'Souza DC.

Biol Psychiatry. 2014 Sep 15;76(6):495-502. doi: 10.1016/j.biopsych.2013.11.001. Epub 2013 Nov 13.

PMID:
24360979
8.

Distinct effects of duration of untreated psychosis on brain cortical activities in different treatment phases of schizophrenia: a multi-channel near-infrared spectroscopy study.

Chou PH, Koike S, Nishimura Y, Kawasaki S, Satomura Y, Kinoshita A, Takizawa R, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:63-9. doi: 10.1016/j.pnpbp.2013.11.009. Epub 2013 Nov 22.

PMID:
24275075
9.

Molecular imaging as a guide for the treatment of central nervous system disorders.

Kim E, Howes OD, Kapur S.

Dialogues Clin Neurosci. 2013 Sep;15(3):315-28. Review.

10.

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.

Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR.

Mol Psychiatry. 2014 Jan;19(1):20-9. doi: 10.1038/mp.2013.136. Epub 2013 Oct 29. Review.

PMID:
24166406
11.

Meditation improves self-regulation over the life span.

Tang YY, Posner MI, Rothbart MK.

Ann N Y Acad Sci. 2014 Jan;1307:104-11. doi: 10.1111/nyas.12227. Epub 2013 Aug 22.

12.

Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis.

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K.

J Clin Psychopharmacol. 2013 Oct;33(5):675-81. doi: 10.1097/JCP.0b013e3182983ffa. Review.

PMID:
23948784
13.

Cavum septum pellucidum and cavum vergae with late-onset catatonia.

Yasaki T, Takahashi Y, Takahashi T, Washizuka S, Amano N, Hanihara T.

J ECT. 2013 Sep;29(3):e45-6. doi: 10.1097/YCT.0b013e318290fc13.

PMID:
23670024
14.

Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review.

Busatto GF.

Schizophr Bull. 2013 Jul;39(4):776-86. doi: 10.1093/schbul/sbt054. Epub 2013 Apr 24. Review.

15.

Limbic hyperactivity associated to verbal memory deficit in schizophrenia.

Suazo V, Díez Á, Tamayo P, Montes C, Molina V.

J Psychiatr Res. 2013 Jun;47(6):843-50. doi: 10.1016/j.jpsychires.2013.02.007. Epub 2013 Mar 13.

PMID:
23490064
16.

Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans.

Jasinska AJ, Zorick T, Brody AL, Stein EA.

Neuropharmacology. 2014 Sep;84:111-22. doi: 10.1016/j.neuropharm.2013.02.015. Epub 2013 Mar 6. Review.

17.

Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.

de Jong MH, Zemel D, Van Gool AR.

Clin Schizophr Relat Psychoses. 2014 Apr;8(1):36-40. doi: 10.3371/CSRP.DEZE.012513.

PMID:
23428786
18.

Transcranial magnetic stimulation in schizophrenia: the contribution of neuroimaging.

Du ZD, Wang R, Prakash R, Chaudhury S, Dayananda G.

Curr Top Med Chem. 2012;12(21):2452-7. Review.

PMID:
23409741
19.

EEG microstates associated with salience and frontoparietal networks in frontotemporal dementia, schizophrenia and Alzheimer's disease.

Nishida K, Morishima Y, Yoshimura M, Isotani T, Irisawa S, Jann K, Dierks T, Strik W, Kinoshita T, Koenig T.

Clin Neurophysiol. 2013 Jun;124(6):1106-14. doi: 10.1016/j.clinph.2013.01.005. Epub 2013 Feb 9.

PMID:
23403263
20.

In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.

Tavares AA, Batis J, Barret O, Alagille D, Vala C, Kudej G, Koren A, Cosgrove KP, Nice K, Kordower JH, Seibyl J, Tamagnan GD.

Nucl Med Biol. 2013 Apr;40(3):403-9. doi: 10.1016/j.nucmedbio.2012.12.005. Epub 2013 Jan 16.

PMID:
23332393
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk